{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:45:27Z","timestamp":1786193127465,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82560520"],"award-info":[{"award-number":["82560520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260580"],"award-info":[{"award-number":["82260580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangxi Natural Science Foundation","award":["2025GXNSFAA069580"],"award-info":[{"award-number":["2025GXNSFAA069580"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05129-8","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:34:12Z","timestamp":1782218052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["iRGD-modified 3D exosomes delivered miR-99b-5p induces ferroptosis to inhibit colorectal cancer progression by regulating FGFR3\/PI3K\/AKt pathway"],"prefix":"10.1186","volume":"17","author":[{"given":"Xiao-huan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-tu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-fang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"3","key":"5129_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"5129_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","volume":"21","author":"A Canellas-Socias","year":"2024","unstructured":"Canellas-Socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21(9):609\u201325.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5129_CR3","doi-asserted-by":"publisher","first-page":"1412363","DOI":"10.3389\/fcell.2024.1412363","volume":"12","author":"T Zhao","year":"2024","unstructured":"Zhao T, Mu Y, Deng H, Liang K, Zhou F, Lin Q, et al. Research hotspots and trends of mesenchymal stem cell-derived extracellular vesicles for drug delivery: a bibliometric and visualization analysis from 2013 to 2023. Front Cell Dev Biol. 2024;12:1412363.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"5129_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.7150\/ijbs.101937","volume":"21","author":"Y Li","year":"2025","unstructured":"Li Y, Quan X, Hu J, Han Y, Chen J, Zhou M, et al. BMSCs-derived small extracellular vesicles antagonize cerebral endothelial Caveolin-1 driven autophagic degradation of tight-junction proteins to protect blood-brain barrier post-stroke. Int J Biol Sci. 2025;21(2):842\u201359.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5129_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"5129_CR6","doi-asserted-by":"publisher","first-page":"e12235","DOI":"10.1002\/jev2.12235","volume":"11","author":"X Yuan","year":"2022","unstructured":"Yuan X, Sun L, Jeske R, Nkosi D, York SB, Liu Y, et al. Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells. J Extracell Vesicles. 2022;11(6):e12235.","journal-title":"J Extracell Vesicles"},{"issue":"16","key":"5129_CR7","doi-asserted-by":"publisher","first-page":"e2500637","DOI":"10.1002\/advs.202500637","volume":"12","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lin F, Zhang T, Xiao Z, Chen Y, Hua D, et al. Engineering Extracellular Vesicles Derived from 3D Cultivation of BMSCs Enriched with HGF Ameliorate Sepsis-Induced Lung Epithelial Barrier Damage. Adv Sci (Weinh). 2025;12(16):e2500637.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5129_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12951-022-01462-1","volume":"20","author":"C Wang","year":"2022","unstructured":"Wang C, Li N, Li Y, Hou S, Zhang W, Meng Z, et al. Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy\/internal irradiation combination therapy. J Nanobiotechnol. 2022;20(1):247.","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"5129_CR9","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1021\/acsami.9b21214","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xie Y, Kilchrist KV, Li J, Duvall CL, Oupicky D. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA\/miRNA Combination Cancer Therapy. ACS Appl Mater Interfaces. 2020;12(4):4308\u201322.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"5129_CR10","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s12015-023-10606-1","volume":"19","author":"S Ning","year":"2023","unstructured":"Ning S, Chen Y, Li S, Liu M, Liu H, Ye M, et al. Exosomal miR-99b-5p Secreted from Mesenchymal Stem Cells Can Retard the Progression of Colorectal Cancer by Targeting FGFR3. Stem Cell Rev Rep. 2023;19(8):2901\u201317.","journal-title":"Stem Cell Rev Rep"},{"issue":"31","key":"5129_CR11","doi-asserted-by":"publisher","first-page":"e2404064","DOI":"10.1002\/advs.202404064","volume":"11","author":"Q Wang","year":"2024","unstructured":"Wang Q, Guo W, Niu L, Zhou Y, Wang Z, Chen J, et al. 3D-hUMSCs Exosomes Ameliorate Vitiligo by Simultaneously Potentiating Treg Cells-Mediated Immunosuppression and Suppressing Oxidative Stress-Induced Melanocyte Damage. Adv Sci (Weinh). 2024;11(31):e2404064.","journal-title":"Adv Sci (Weinh)"},{"issue":"17","key":"5129_CR12","doi-asserted-by":"publisher","first-page":"e2300552","DOI":"10.1002\/advs.202300552","volume":"10","author":"L Wang","year":"2023","unstructured":"Wang L, Wang D, Ye Z, Xu J. Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications. Adv Sci (Weinh). 2023;10(17):e2300552.","journal-title":"Adv Sci (Weinh)"},{"key":"5129_CR13","first-page":"338","volume":"52","author":"J Huang","year":"2025","unstructured":"Huang J, Chen H, Li N, Liu P, Yang J, Zhao Y. Emerging technologies towards extracellular vesicles large-scale production. Bioact Mater. 2025;52:338\u201365.","journal-title":"Bioact Mater"},{"key":"5129_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063186","author":"RE Thompson","year":"2022","unstructured":"Thompson RE, Bouma GJ, Hollinshead FK. The roles of extracellular vesicles and organoid models in female reproductive physiology. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23063186.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5129_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s44222-024-00255-5","volume":"3","author":"M Manno","year":"2025","unstructured":"Manno M, Bongiovanni A, Margolis L, Bergese P, Arosio P. The physico-chemical landscape of extracellular vesicles. Nat Reviews Bioeng. 2025;3(1):68\u201382.","journal-title":"Nat Reviews Bioeng"},{"key":"5129_CR16","doi-asserted-by":"publisher","first-page":"216093","DOI":"10.1016\/j.canlet.2023.216093","volume":"558","author":"R Raguraman","year":"2023","unstructured":"Raguraman R, Bhavsar D, Kim D, Ren X, Sikavitsas V, Munshi A, et al. Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Lett. 2023;558:216093.","journal-title":"Cancer Lett"},{"issue":"5981","key":"5129_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.1183057","volume":"328","author":"KN Sugahara","year":"2010","unstructured":"Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR, et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science. 2010;328(5981):1031\u20135.","journal-title":"Science"},{"issue":"47","key":"5129_CR18","doi-asserted-by":"publisher","first-page":"e2407370","DOI":"10.1002\/advs.202407370","volume":"11","author":"Y Gan","year":"2024","unstructured":"Gan Y, Hao Q, Han T, Tong J, Yan Q, Zhong H, et al. Targeting BRIX1 via Engineered Exosomes Induces Nucleolar Stress to Suppress Cancer Progression. Adv Sci (Weinh). 2024;11(47):e2407370.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5129_CR19","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/s41467-017-01841-5","volume":"8","author":"R Simeoli","year":"2017","unstructured":"Simeoli R, Montague K, Jones HR, Castaldi L, Chambers D, Kelleher JH, et al. Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma. Nat Commun. 2017;8(1):1778.","journal-title":"Nat Commun"},{"key":"5129_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000517","author":"L Wang","year":"2020","unstructured":"Wang L, Hu YY, Zhao JL, Huang F, Liang SQ, Dong L, et al. Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2019-000517.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"5129_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.ymthe.2022.01.004","volume":"30","author":"H Holliday","year":"2022","unstructured":"Holliday H, Yang J, Dodson E, Nikolic I, Kamili A, Wheatley M, et al. miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma. Mol Ther. 2022;30(3):1119\u201334.","journal-title":"Mol Ther"},{"key":"5129_CR22","doi-asserted-by":"publisher","first-page":"799060","DOI":"10.3389\/fmolb.2021.799060","volume":"8","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu H, Ning S, Wei C, Li J, Wei W, et al. The High Ratio of the Plasma miR-96\/miR-99b Correlated With Poor Prognosis in Patients With Metastatic Colorectal Cancer. Front Mol Biosci. 2021;8:799060.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"5129_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"GJ Goodall","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22\u201336.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5129_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425.","journal-title":"Signal Transduct Target Ther"},{"key":"5129_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186035","author":"AE Shin","year":"2025","unstructured":"Shin AE, Sugiura K, Kariuki SW, Cohen DA, Flashner SP, Klein-Szanto AJ, et al. LIN28B-mediated PI3K\/AKT pathway activation promotes metastasis in colorectal cancer models. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI186035.","journal-title":"J Clin Invest"},{"key":"5129_CR26","doi-asserted-by":"publisher","first-page":"114536","DOI":"10.1016\/j.bcp.2021.114536","volume":"190","author":"J Zhao","year":"2021","unstructured":"Zhao J, Tan W, Zhang L, Liu J, Shangguan M, Chen J, et al. FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer. Biochem Pharmacol. 2021;190:114536.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"5129_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tcb.2022.11.003","volume":"33","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Johnson CH. Targeting ferroptosis to treat colorectal cancer. Trends Cell Biol. 2023;33(3):185\u20138.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"5129_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13287-025-04511-2","volume":"16","author":"M Zayed","year":"2025","unstructured":"Zayed M, Elwakeel E, Ezzat P, Jeong BH. Mesenchymal stem cell-derived exosomes as a potential therapeutic strategy for ferroptosis. Stem Cell Res Ther. 2025;16(1):368.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5129_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.","journal-title":"Mol Cancer"},{"key":"5129_CR30","doi-asserted-by":"publisher","first-page":"155984","DOI":"10.1016\/j.prp.2025.155984","volume":"270","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Ahmed HH, Sanghvi G, Bin Awang Isa MZ, Singh P, Kaur K, et al. Recent advances in the delivery of microRNAs via exosomes derived from MSCs, and their role in regulation of ferroptosis. Pathol Res Pract. 2025;270:155984.","journal-title":"Pathol Res Pract"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05129-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:29:17Z","timestamp":1786192157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05129-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5129"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05129-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were approved by the Animal Experiments Ethics Committee of Guangxi Medical University Cancer Hospital. [Project title: The role and mechanism of engineering mesenchymal stem cell-derived exosomes carrying miR-99b-5p in targeted therapy of CRC]. (Approval number: KY-2022-130, Date of approval: February 25th, 2022). The treatment of animals in this study conforms to the ethical standards of experimental animals. The human CRC cells (LoVo and SW480) used in this research were purchased from the Cell Bank, Chinese Academy of Sciences (Shanghai, China). The human bone MSCs were purchased from Haixing Biosciences Co., Ltd in Suzhou, China. According to the vendor, the original source of these cells followed rigorous ethical standards during the collection process, including the acquisition of institutional ethical approval and informed consent from the donors.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"273"}}